No Data
No Data
Express News | NYSE Order Imbalance 90909.0 Shares on Sell Side
Piper Sandler Releases a Hold Rating on Core Laboratories (CLB)
Core Laboratories Inc.'s (NYSE:CLB) CEO Compensation Is Looking A Bit Stretched At The Moment
Are Investors Undervaluing Core Laboratories Inc. (NYSE:CLB) By 35%?
Key Insights Core Laboratories' estimated fair value is US$24.29 based on 2 Stage Free Cash Flow to Equity Current share price of US$15.80 suggests Core Laboratories is potentially 35% undervalued
These Return Metrics Don't Make Core Laboratories (NYSE:CLB) Look Too Strong
Core Labs Is Maintained at Hold by Stifel
Core Labs Is Maintained at Hold by Stifel